Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

72 trials with published results (17%)

Research Maturity

297 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.6%

15 terminated out of 415 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

27%

113 trials in Phase 3/4

Results Transparency

24%

72 of 297 completed with results

Key Signals

72 with results95% success15 terminated

Data Visualizations

Phase Distribution

359Total
Not Applicable (139)
Early P 1 (1)
P 1 (57)
P 2 (49)
P 3 (72)
P 4 (41)

Trial Status

Completed297
Unknown49
Recruiting23
Terminated15
Not Yet Recruiting14
Withdrawn8

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 297 completed trials

Clinical Trials (415)

Showing 20 of 20 trials
NCT07730567Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

NCT02262806Phase 2Active Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

NCT07722299Phase 1Not Yet RecruitingPrimary

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants

NCT07720232Phase 4Recruiting

Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT

NCT02262832Phase 3Active Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

NCT07712042Not Yet RecruitingPrimary

Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals

NCT07710898Not ApplicableCompleted

Amelioration of Lipid Profile Through Date Cider-vinegar Along With 5:2 Intermittent Fasting

NCT07696559Not ApplicableCompletedPrimary

Effect of the β-sitosterol-enriched Dietary Plan on Lipid Levels.

NCT07685639Not ApplicableNot Yet Recruiting

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

NCT06684106Not ApplicableRecruitingPrimary

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

NCT07674524Not Yet Recruiting

Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

NCT07216482Phase 3Active Not RecruitingPrimary

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

NCT07662330Not ApplicableRecruiting

Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

NCT07100418Phase 2Active Not RecruitingPrimary

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

NCT00001154Completed

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

NCT07578090Recruiting

Regional Innovation in Chronic Disease and Elderly Care

NCT07230730Phase 3RecruitingPrimary

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

NCT07588256Not ApplicableRecruiting

New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases

NCT06603363Not ApplicableRecruiting

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

NCT06951451Not ApplicableEnrolling By Invitation

Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman

Scroll to load more

Research Network

Activity Timeline